Cleared Traditional

K162958 - MYOtherm XP Cardioplegia Delivery System with Trillium Biosurface (FDA 510(k) Clearance)

Also includes:
MYOtherm XP Cardioplegia Delivery System with Trillium Biosurface with Bridge MYOtherm XP Cardioplegia Delivery System MYOtherm XP Cardioplegia Delivery System with Bridge
Feb 2017
Decision
100d
Days
Class 2
Risk

K162958 is an FDA 510(k) clearance for the MYOtherm XP Cardioplegia Delivery System with Trillium Biosurface. This device is classified as a Heat-exchanger, Cardiopulmonary Bypass (Class II - Special Controls, product code DTR).

Submitted by Medtronic, Inc. (Minneapolis, US). The FDA issued a Cleared decision on February 1, 2017, 100 days after receiving the submission on October 24, 2016.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4240.

Submission Details

510(k) Number K162958 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 2016
Decision Date February 01, 2017
Days to Decision 100 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DTR — Heat-exchanger, Cardiopulmonary Bypass
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4240